Wikidata

(Q83517121)

English

A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors

scientific article published on 15 March 2011

In more languages

Statements

title
A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21368575
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368575%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q83517121&oldid=1651664850"